Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment.
Beamer, Gillian
Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment. [electronic resource] - The American journal of pathology Dec 2014 - 3170-5 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1525-2191
10.1016/j.ajpath.2014.08.024 doi
Adapalene
Animals
Anti-Bacterial Agents--therapeutic use
Antitubercular Agents--therapeutic use
Bone Marrow--microbiology
Bone Marrow Cells--microbiology
Disease Models, Animal
Drug Resistance, Bacterial
Female
Humans
Isoniazid--therapeutic use
Leukocyte Common Antigens--metabolism
Lung--microbiology
Mesenchymal Stem Cells--microbiology
Mice
Mice, Inbred C57BL
Mycobacterium tuberculosis--drug effects
Naphthalenes--metabolism
Rifampin--therapeutic use
Spleen--microbiology
Tuberculosis--drug therapy
Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment. [electronic resource] - The American journal of pathology Dec 2014 - 3170-5 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1525-2191
10.1016/j.ajpath.2014.08.024 doi
Adapalene
Animals
Anti-Bacterial Agents--therapeutic use
Antitubercular Agents--therapeutic use
Bone Marrow--microbiology
Bone Marrow Cells--microbiology
Disease Models, Animal
Drug Resistance, Bacterial
Female
Humans
Isoniazid--therapeutic use
Leukocyte Common Antigens--metabolism
Lung--microbiology
Mesenchymal Stem Cells--microbiology
Mice
Mice, Inbred C57BL
Mycobacterium tuberculosis--drug effects
Naphthalenes--metabolism
Rifampin--therapeutic use
Spleen--microbiology
Tuberculosis--drug therapy